Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly

Clinical trial NCT02557620 · COMPLETED

Trial details

NCT number: NCT02557620
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diabetes Healthy

Start date: 2015-09-01
Primary completion: 2016-04-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.